Tandem Diabetes Care
TNDM
TNDM
268 hedge funds and large institutions have $2.12B invested in Tandem Diabetes Care in 2023 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 84 increasing their positions, 86 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 86
27% less call options, than puts
Call options by funds: $13.2M | Put options by funds: $18.3M
Holders
268
Holding in Top 10
2
Calls
$13.2M
Puts
$18.3M
Top Buyers
| 1 | +$38.6M | |
| 2 | +$36.3M | |
| 3 | +$29.3M | |
| 4 |
Morgan Stanley
New York
|
+$28.7M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$14.7M |
Top Sellers
| 1 | -$32M | |
| 2 | -$24.5M | |
| 3 | -$21M | |
| 4 |
PIM
Paradice Investment Management
Denver,
Colorado
|
-$13M |
| 5 |
CC
Chicago Capital
Chicago,
Illinois
|
-$12.6M |